NINDS Payline

A NINDS payline is the percentile-rank threshold that the National Institute of Neurological Disorders and Stroke (NINDS), one of NIH’s 27 institutes and centers, sets for a fiscal year to guide which peer-reviewed grant applications it expects to fund. It is NINDS’s own institute-specific application of the general NIH payline mechanism — the same underlying concept CASRAI’s NHLBI Payline guide describes for the National Heart, Lung, and Blood Institute — not a separate mechanism unique to neuroscience research. Each NIH institute sets its payline independently against its own appropriation, application volume, and priorities, so a NINDS figure should never be assumed to match NHLBI’s, NIAID’s, or any other institute’s figure for the same fiscal year and mechanism.

What the NINDS payline covers

After initial peer review at an NIH study section, an application receives an impact score that is converted into a percentile rank relative to comparable applications reviewed over a recent review cycle. NINDS publishes, on its own funding-likelihood pages, the percentile rank below which it currently expects to fund applications for a given grant mechanism and fiscal year. NINDS refers to this figure on its site as a “payline,” consistent with how the term is used across the research-administration community, though — as with other institutes — the published number functions as a planning guideline rather than an absolute, contractually binding cutoff.

NINDS’s Early Stage Investigator differential

Like most NIH institutes, NINDS publishes a more generous, “extended” payline for Early Stage Investigators (ESIs) — researchers within 10 years of completing their terminal research degree or clinical training who have not yet received a substantial NIH independent research award — than for established investigators competing for the same mechanism. NINDS describes the purpose of this extended payline explicitly as normalizing the R01 success rate for early-stage investigators so it is comparable to the success rate of established investigators applying for new R01 awards, funding additional ESI applications that score beyond the standard payline to achieve that aim. Public reporting on NINDS’s own funding-likelihood pages has described nearly all ESI R01 applications as funded to roughly the 25th percentile in a recent fiscal year. Sourcing note: NINDS’s own “Understanding Paylines” and “NINDS Paylines” pages (ninds.nih.gov) returned an access error on direct verification for this entry; the specifics above are corroborated via independent WebSearch synthesis of NINDS’s own page titles/content rather than a direct fetch — treat the ESI mechanism description as accurate in substance (consistent with how other NIH institutes apply the same ESI-differential policy) but treat any specific current percentile figure as REPORTED-tier, and confirm against NINDS’s current paylines page before using a number in a proposal or planning conversation. See CASRAI’s Early Stage Investigator (ESI) entry for how ESI eligibility is determined and tracked in eRA Commons.

NINDS payline vs. percentile score

These two numbers are often conflated but are not the same thing:

• Percentile rank — assigned to an individual application after peer review, based on how its impact score compares to other applications reviewed in the same or a comparable study section over a recent cycle. This appears on the applicant’s summary statement.
• NINDS payline — a property of the institute, not the application: the percentile threshold NINDS sets for a fiscal year and mechanism, based on that year’s appropriation, application volume, and research priorities, as a guide to which percentile ranks it currently expects to fund.

An application’s percentile is fixed at review; NINDS’s payline for that fiscal year and mechanism is set independently and can differ from the payline any other NIH institute sets for the same percentile-scoring application.

How and when NINDS sets and updates its payline

Consistent with other NIH institutes, NINDS typically issues its funding guidance after the federal appropriation for the fiscal year is known, or based on continuing-resolution levels when a final appropriation has not yet passed, and revisits that guidance as actual application volume and remaining budget become clearer over the course of the year. Because of this, an early-fiscal-year NINDS payline can be conservative relative to where the year ultimately lands, and institutes routinely describe published guidance as subject to change. NINDS also publishes separate figures by mechanism (for example, R01 versus R21 or R03) rather than a single institute-wide number, and, as noted above, a separate extended figure for Early Stage Investigators. Applicants and research administrators should check NINDS’s current funding-likelihood pages directly for the fiscal year and mechanism in question rather than relying on a previously cited number.

A guideline, not a guarantee, in either direction

Scoring inside NINDS’s published payline does not guarantee funding, and scoring outside it does not guarantee rejection. As with other NIH institutes, NINDS retains discretion through mechanisms that operate independently of the payline itself:

• Advisory council review — a second level of review, separate from the study section, weighing programmatic relevance and portfolio balance alongside the percentile score.
• Select pay / exception pay — discretionary funding of applications that score outside the published payline, based on program priority and available budget.
• Program priorities — alignment with NINDS’s strategic research priorities can factor into funding decisions alongside the percentile and payline.

For this reason, research administrators typically treat the NINDS payline as a planning benchmark for budgeting and resubmission-timing decisions, not as the sole determinant of whether an application will be funded.

A significant recent development: NIH moving away from published paylines

In a November 2025 announcement on its Extramural Nexus News page, NIH stated that its institutes and centers “will not rely on funding paylines in developing pay plans” going forward, signaling a shift toward weighing peer-review scores against institute priorities, strategic plans, and budget more holistically rather than publishing a fixed percentile cutoff. Sourcing note: the primary grants.nih.gov page describing this change returned an access error on direct verification; the substance is corroborated by independent secondary coverage quoting the same NIH language — treat as REPORTED-tier and confirm current NINDS practice against its own current guidance rather than assuming a traditional payline is still published for every mechanism and fiscal year. See CASRAI’s NIH Payline entry for the general mechanism and this policy signal in fuller context.

NINDS payline vs. NHLBI payline vs. the general NIH payline

“NINDS payline,” “NHLBI payline,” and “NIH payline” describe the same underlying mechanism applied at three different levels of specificity. “NIH payline” (see CASRAI’s NIH Payline entry) is the general concept: every NIH institute sets one independently, and no single agency-wide figure exists. “NHLBI payline” and “NINDS payline” are two institutes’ specific applications of that same mechanism — each set independently, against each institute’s own appropriation and applicant pool, and each capable of differing meaningfully from the other for the same fiscal year and grant mechanism. See CASRAI’s NHLBI Payline guide for a worked example of how one specific institute applies the mechanism, including a labeled fiscal-year snapshot.

Frequently asked questions

Is the NINDS payline the same as the NIH payline?

No. There is no single NIH-wide payline. NINDS sets its own payline independently, based on its own appropriation, application volume, and priorities, and it will typically differ from the figure any other NIH institute or center sets for the same fiscal year and mechanism.

Does NINDS publish one payline for all grant types?

No. NINDS, like other NIH institutes, commonly publishes separate figures by mechanism (for example, R01 versus R21) and a separate, more generous extended payline for Early Stage Investigators rather than a single institute-wide number.

What’s the difference between the NINDS payline and a percentile score?

A percentile score is assigned to an individual application after peer review, reflecting how it ranked against comparable applications. The NINDS payline is the institute’s own threshold, set independently for the fiscal year and mechanism, describing which percentile ranks it currently expects to fund.

Can an application score outside the NINDS payline and still get funded?

Yes. NINDS retains discretion through advisory council review, select-pay/exception-pay decisions, and program priorities, so the payline functions as a planning guideline rather than an automatic cutoff in either direction.

Where do I find NINDS’s current payline?

Check NINDS’s own current funding-likelihood pages directly for the fiscal year and mechanism in question, since these figures are set annually, vary by mechanism and career stage, and can be revised within a fiscal year — and since NIH signaled in November 2025 that institutes are moving away from relying on fixed published paylines altogether.